Live tape
Top 8, mentions 7d28,232NVDA13,675 mentions▲ +0.04ANT3,819 mentions▲ +0.06GOOGL2,744 mentions▲ +0.04SPY2,166 mentions▲ +0.05QQQ1,729 mentions▲ +0.04SPCX1,673 mentions▲ +0.08AMD1,299 mentions▲ +0.06AAPL1,127 mentions▲ +0.04

Equity · Healthcare

MGX

NASDAQ

Metagenomi (MGX)

0.6303 USD −6.15% vs prior close Nov 17, 2026
Metagenomi Therapeutics, Inc. price graph
48 sessions
1.4 0.6 24 Aug 17 Nov

The line runs 1.22 USD on 24 August through 0.6303 USD on 17 November, on a scale from 0.6 to 1.4. Days the market did not trade hold the previous close, flat.

Market cap
23.8M USD
Revenue, year to Dec 2025
25.2M USD
EPS, diluted, year to Dec 2025
−2.36 USD
52-week range
0.6303 USD – 2.15 USD
Avg volume
4.8K

as of Nov 17, 2026

Have Metagenomi (MGX) insiders bought or sold shares recently?

In the 90 days to 21 Nov 2026, Metagenomi insiders reported 3 open-market sales and 1 purchase (SEC Form 4).

Form 4, 90 days to 21 Nov 2026, newest reported trade 9 Sep 2026

1buys
3sells
$18Knet bought
0other filings
Have Metagenomi (MGX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
09 Sep 2026Reid LaurenceDirectorBuy20,00023K USD
08 Sep 2026Wein MatthewSee RemarksSell358415 USD
08 Sep 2026Irish JianSee RemarksSell2,1402K USD
08 Sep 2026Wapnick PamelaChief Financial OfficerSell1,9112K USD
Bought1 open-market purchase20,000$23K
Sold3 open-market sales4,409$5K

Which funds hold Metagenomi (MGX)?

5 of the 45 institutional funds we track reported a Metagenomi position for the quarter ended 30 Sep 2026 — a combined 1.5M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Metagenomi (MGX)?
FundPositionSharesValueShares q/q
Renaissance TechnologiesHeld (±25%)624,300662K USD−15.9%
Two Sigma InvestmentsHeld (±25%)504,515535K USD−1.8%
Man GroupAdded141,896150K USD+30.0%
Millennium ManagementTrimmed75,40280K USD−33.9%
Citadel AdvisorsAdded49,26652K USD+176.0%

What has been filed or recorded for Metagenomi (MGX)?

The filings we hold for Metagenomi, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 28 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Metagenomi (MGX)?
And
28 Oct 2026Fails to deliverShares failed to deliver8,531 shares7K USD notional · 0.023% of shares out
13 Oct 2026Fails to deliverShares failed to deliver1,997 shares2K USD notional · 0.005% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.56 USDRevenue $2M
30 Sep 2026FinancialsTotal assets157.4M USDat period end
30 Sep 2026FinancialsTotal equity93.2M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.73 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.61 USDRevenue $1M
31 Dec 2025Annual reportFY 2025 reportedEPS −2.36 USDRevenue $25M
31 Dec 2025FinancialsRevenue25.2M USDfiscal year
31 Dec 2025FinancialsNet income−87.9M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−2.36 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.55 USDRevenue $9M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.54 USDRevenue $9M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.68 USDRevenue $4M
31 Dec 2024Annual reportFY 2024 reportedEPS −2.36 USDRevenue $52M

What do people ask about Metagenomi (MGX)?

From live data
What did Metagenomi shares close at?0.6303

Metagenomi closed at 0.6303 USD on 17 Nov 2026, down 6.15% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Metagenomi’s market cap?23.8M

Metagenomi is worth 23.8M USD by market value as of 17 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is Metagenomi’s revenue?25.2M

Metagenomi reported revenue of 25.2M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Metagenomi insiders bought or sold shares recently?3 sales

In the 90 days to 21 Nov 2026, Metagenomi insiders reported 3 open-market sales and 1 purchase (SEC Form 4). See Insiders

Which funds own Metagenomi?5 of 45

5 of the 45 funds we track reported a Metagenomi position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, Two Sigma Investments and Man Group. See Funds

When did Metagenomi last report earnings?−0.56

Metagenomi last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.56 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings
  9. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words